Difficulty: Medium
Average Score: 87%
Practice
Following are irreversible anti-cholinesterases, except
Correct answer
B
Rationale
In this question, the correct answer is B) Pyridostigmine. Pyridostigmine is a reversible anti-cholinesterase, unlike the other options provided.
Parathion (Option A), Dyflos (Option C), and Ecothiopate (Option D) are all irreversible anti-cholinesterases. These agents form a stable covalent bond with the active site of acetylcholinesterase enzyme, leading to long-lasting inhibition of the enzyme activity. This results in the accumulation of acetylcholine at the synaptic cleft, leading to prolonged cholinergic effects.
Educationally, understanding the classification of anti-cholinesterases as either reversible or irreversible is crucial in the pharmacological management of conditions such as myasthenia gravis and nerve agent poisoning. Reversible anti-cholinesterases are preferred in clinical practice due to their shorter duration of action and the ability to be easily reversed with antidotes like atropine, whereas irreversible anti-cholinesterases may cause prolonged cholinergic effects that are harder to manage. This knowledge is essential for healthcare professionals prescribing these drugs and managing patients with cholinergic toxicity.
Parathion (Option A), Dyflos (Option C), and Ecothiopate (Option D) are all irreversible anti-cholinesterases. These agents form a stable covalent bond with the active site of acetylcholinesterase enzyme, leading to long-lasting inhibition of the enzyme activity. This results in the accumulation of acetylcholine at the synaptic cleft, leading to prolonged cholinergic effects.
Educationally, understanding the classification of anti-cholinesterases as either reversible or irreversible is crucial in the pharmacological management of conditions such as myasthenia gravis and nerve agent poisoning. Reversible anti-cholinesterases are preferred in clinical practice due to their shorter duration of action and the ability to be easily reversed with antidotes like atropine, whereas irreversible anti-cholinesterases may cause prolonged cholinergic effects that are harder to manage. This knowledge is essential for healthcare professionals prescribing these drugs and managing patients with cholinergic toxicity.